Time to buy up, page-81

I think what Christine Holgate is underestimating is the caution investors have for regulatory intervention and for forward uncertainty as to what else might be coming.

There are a lot of regulatory changes being proposed that we know of and perhaps others that we don’t yet know of.

The market isn’t selling the taxation change, it’s a cautionary response to all the changes and perhaps some expectation of an end game agenda by China which could take several months yet to play out.

Those of us who were invested in A2M in 2014 saw the same thing, there was no direct numerical risk at that time to the first round of Chinese regulatory changes either, yet it initiated a 50% drop in share price and a one year long correction.

Not suggesting that happens this time around, I hope not, although it seems to be a bit of a deja vu moment at present in some respects.
.